Business
Result of General Meeting
Result of General Meeting.
About this update from Kromek Group Plc
[{"type":"text","content":"\n\n4 March 2024\n \nKromek Group plc\n(\"Kromek\" or the \"Group\")\n \nResult of General Meeting\n \nKromek Group plc, a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that at a General Meeting held earlier today, all resolutions were duly passed.\n \nDetails of the proxy voting results, which should be read alongside the Notice of General Meeting, are below:\n \n\n\n\n\nResolution\n\n\nVotes for\n\n\nVotes against\n\n\nVotes withheld\n\n\nTotal proxy votes\n\n\n\n\n\n\n\nNo. of votes\n\n\n% of votes cast*\n\n\nNo. of votes\n\n\n% of votes cast*\n\n\nNo. of votes\n\n\n\n\n\n\n\n1\n\n\n208,359,813\n\n\n99.30\n\n\n1,468,177\n\n\n0.70\n\n\n865,908\n\n\n210,693,898\n\n\n\n\n2\n\n\n207,152,990\n\n\n98.62\n\n\n2,895,210\n\n\n1.38\n\n\n645,698\n\n\n210,693,898\n\n\n\n\n*Excludes withheld votes\n \n \nFor further information, please contact: \n \n\n\n\n\nKromek Group plc \n\n\n\n\n\n\n\nArnab Basu, CEO \nPaul Farquhar, CFO \n\n\n+44 (0)1740 626 060\n\n\n\n\n \n\n\n\n\n\n\n\nCavendish Capital Markets Limited (Nominated Adviser and Broker) \n\n\n \n\n\n\n\nGeoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance \nTim Redfern - ECM \n\n\n+44 (0)20 7220 0500 \n \n\n\n\n\nMichael Johnson/Tamar Cranford-Smith - Sales\n \n\n\n\n\n\n\n\nGracechurch Group (Financial PR) \n\n\n\n\n\n\n\nHarry Chathli/Claire Norbury/Henry Gamble \n\n\n+44 (0)20 4582 3500\n\n\n\n\n \n \nKromek Group plc \n \nKromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions. \n \nThe advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.&nbs...